Dual Combination ART with Cabotegravir and Rilpivirine Is Effective for Maintaining HIV Virological Suppression.

Title

Dual Combination ART with Cabotegravir and Rilpivirine Is Effective for Maintaining HIV Virological Suppression.

Creator

Watkins Richard R

Publisher

Infectious Disease Alert

Date

2015
2015-11

Description

Results of the phase 2 LATTE study show that after 24 weeks of induction triple therapy, maintenance therapy with cabotegravir (a long-acting dolutegravir analogue) and rilpivirine led to virological suppression in 82% of patients, compared to 71 % who received efavirenz plus two NRTIs.

Subject

Adverse Drug Event; Anti-HIV Agents; Antiviral Agents – Therapeutic Use; Drug Combinations – Therapeutic Use

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

16–17

Issue

2

Volume

35

Citation

Watkins Richard R, “Dual Combination ART with Cabotegravir and Rilpivirine Is Effective for Maintaining HIV Virological Suppression.,” NEOMED Bibliography Database, accessed January 27, 2022, https://neomed.omeka.net/items/show/5872.

Social Bookmarking